Hypereosinophilic vasculitis: A case report.

Medicine (Baltimore)

IAU-KFHU, SCFHS, Khobar, Saudi Arabia.

Published: April 2019

AI Article Synopsis

Article Abstract

Introduction: The Revised International Chapel Hill Consensus Conference 2012 subdivides vasculitides based on combinations of features that separate different forms of vasculitis into definable categories. Hypereosinophilic vasculitis with sparing of the respiratory tract and renal system is a rare presentation that is yet to be described in the Revised International Chapel Hill Consensus Conference 2012 report that addresses nomenclature of vasculitides. This is a condition that involves a vascular injury due to either a primary eosinophilic vasculitis or an underlying connective tissue disease and it predisposes patients to a prothrombotic state.

Patient Concerns: A 39-year-old patient presented with left hand digital ischemia, preceded by Raynaud phenomenon, and vasculitic rash. For 3 months, he was having digital ischemia affecting the left 2nd and 3rd digits in the form of pallor and gangrenous discoloration with a preceding history of a pinpoint pruritic rash affecting his lower limbs that extended to involve the trunk and upper limbs over a short period of time and responded to only a tapering dose of oral steroids. Examination revealed a delayed capillary refill in all left-hand digits and a weak left radial pulse but no bruit. The rest of his peripheral vascular examination was unremarkable.

Diagnosis: Investigations revealed an absolute eosinophilic count of 4.34 K/μL and erythrocyte sedimentation rate of 44 mm/h. A magnetic resonance angiogram showed a beaded appearance of the left ulnar artery distally and the radial artery branches in the left hand and subsequently was diagnosed with hypereosinophilic vasculitis.

Interventions: He was started on oral prednisone of 1 mg/kg daily orally tapering done as well as azathioprine for maintenance.

Outcomes: Two weeks postdischarge, the patient was seen in the outpatient department where his ischemic symptoms improved, and his skin rash healed. Noticed improvement in his splinter hemorrhages was also detected. He continued to do well on 2 years follow-up CONCLUSION:: This case reflects the importance of frequent reevaluation for vasculitic diseases criteria and nomenclature. Hypereosinophilic vasculitis with absent respiratory and renal involvement is a rare presentation with scarce evidence to guide treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831164PMC
http://dx.doi.org/10.1097/MD.0000000000015392DOI Listing

Publication Analysis

Top Keywords

hypereosinophilic vasculitis
12
revised international
8
international chapel
8
chapel hill
8
hill consensus
8
consensus conference
8
conference 2012
8
rare presentation
8
left hand
8
digital ischemia
8

Similar Publications

Hypereosinophilic diseases represent a heterogeneous group that poses a significant medical challenge. An increased number of eosinophils in the blood can be a dominant symptom of hematologic diseases, such as myeloid hematopoietic cancers or lymphomas. However, it is more commonly associated with other health conditions, such as allergies, infections, and systemic inflammatory diseases.

View Article and Find Full Text PDF

IgG4-related disease for the hematologist.

Hematology Am Soc Hematol Educ Program

December 2024

Division of Hematology, University of British Columbia, Vancouver, British Columbia, Canada; and Division of Hematology, Dalhousie University, Halifax, Nova Scotia, Canada.

Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated disease with many important manifestations in hematopoietic and lymphoid tissue. IgG4 is the least naturally abundant IgG subclass, and the hallmark feature of IgG4-RD is markedly increased IgG4-positive plasma cells (with an IgG4 to IgG ratio >40%) in affected tissue, along with elevated polyclonal serum IgG and IgG4 in most patients. Histological diagnosis is essential, and other key features include storiform fibrosis, lymphoplasmacytic infiltrate, tissue eosinophilia, and obliterative phlebitis.

View Article and Find Full Text PDF

Biologics in Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis.

Immunol Allergy Clin North Am

November 2024

Human Eosinophil Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 4, Room B1-28, 4 Memorial Drive, Bethesda, MD 20892, USA. Electronic address:

Article Synopsis
  • Hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) are disorders characterized by high levels of eosinophils in the blood and tissues, leading to varied symptoms.
  • Traditionally, treatment has relied on systemic glucocorticoids; however, new biologic therapies targeting eosinophils offer alternatives that could lead to better results with fewer side effects.
  • The article reviews the evidence for using these biologics in treating HES and EGPA and outlines how they can be effectively employed in patient care.
View Article and Find Full Text PDF
Article Synopsis
  • A 76-year-old woman with ongoing diarrhea was hospitalized and found to have purpura, high eosinophil levels, and elevated IgG4 antibodies.
  • CT scans showed large amounts of fluid in her abdomen and swelling in her intestines.
  • Skin and gastrointestinal biopsies confirmed eosinophilic gastroenteritis and leukocytoclastic vasculitis but didn't meet criteria for IgG4-related disease, suggesting the connection between eosinophilic gastroenteritis and IgG4-related disease needs more research.
View Article and Find Full Text PDF
Article Synopsis
  • Conventional immunosuppressants are not effective for treating asthma related to Eosinophilic Granulomatosis with Polyangiitis (EGPA).
  • Tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin (TSLP), has shown promise in improving asthma symptoms in patients with severe refractory EGPA-related asthma.
  • Despite improvements in symptoms and asthma control, there are concerns about potential rebound eosinophilia and related complications due to TSLP inhibition, as observed in similar treatments.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!